Teleflex Incorporated

NYSE:TFX

Medical - Instruments & Supplies

Healthcare
$165.85 +0.83%

+$1.04 today

Market cap
$6.58B
Beta
0.82
P/E (TTM)
-5.5
EPS (TTM)
-$22.79
Dividend yield
1.08%
52W Low $100.18High $139.67

Volume 1.16M

Average 0.80M

TFX Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Teleflex IncorporatedNYSE: TFX

Other Income / Expenses · Q2 FY2026 · quarter ended Jun 2026

Other income / expenses remains negative

Q2 FY2026 other income / expenses was -$15.12M, compared with -$20.07M a year earlier. Trailing-twelve-month other income / expenses was -$496.77M.

Context

  • Other income / expenses amounted to 11.6% of revenue in FY2025, up 9.1 pp from a year earlier.
  • Other income / expenses grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other income / expenses holds near -$15.12M or moves back toward the trailing-twelve-month quarterly average of -$124.19M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$15.12M+37.0% QoQ
Last fiscal yearDec 2025
-$231.25M-206.2% YoY
LTMJun 2026
-$496.77M-591.6% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+24.7%——
1 year-206.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
(231.25M) USD
Year-over-year change
-206.2%

Other Income / Expenses vs competitors

How TFX compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -591.6% is the lowest of 11, against a peer median of -9.1%.
  • Other income / expenses amounts to 19.1% of revenue for TFX, versus a peer median of 4.8%.
TFX Competitors
Other Income / Expenses for TFX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PCVXVaxcyte, Inc.LTM Jun 2026$101.03M USD-37.5%+161.6%—
CRSPCRISPR Therapeutics AGLTM Sep 2026$76.21M USD+1284.2%—302.7%
KRYSKrystal Biotech, Inc.LTM Jun 2026$28.7M USD-2.6%+75.4%6.5%
STVNStevanato Group S.p.A.LTM Jun 2026-€4.88M EUR-15.7%—0.4%
MMSIMerit Medical Systems, Inc.LTM Sep 2026-$5.66M USD+76.2%—0.4%
ARWRArrowhead Pharmaceuticals, Inc.LTM Sep 2026-$16.74M USD+64.2%—3.7%
TGTXTG Therapeutics, Inc.LTM Sep 2026-$43.31M USD-188.2%—4.8%
ALKSAlkermes plcLTM Sep 2026-$52.91M USD-224.7%—3.0%
PTCTPTC Therapeutics, Inc.LTM Jun 2026-$183.33M USD-250.6%—18.2%
BLCOBausch + Lomb CorporationLTM Jun 2026-$445M USD+6.3%—8.4%
TFXTeleflex IncorporatedLTM Jun 2026-$496.77M USD-591.6%—19.1%
Peer median (excluding TFX) —-9.1%+118.5%4.8%

Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.81B2.79B2.97B3.05B1.99B
Cost of Revenue1.26B1.26B1.33B1.34B871.96M
Gross Profit1.55B1.53B1.65B1.7B1.12B
Gross Margin55.2%54.9%55.4%55.9%56.2%
Research & Development130.84M153.82M154.35M161.67M144.78M
Selling, General & Admin860.09M863.75M929.87M995.27M720.17M
Operating Expenses921.51M1.03B1.14B1.55B864.95M
Depreciation & Amortization237.36M230.59M242.12M274.6M177.74M
EBITDA853.8M730.77M761.21M433.62M302.51M
EBITDA Margin30.4%26.2%25.6%14.2%15.2%
Operating Income628.1M499.73M506.31M151.01M255.8M
Operating Margin22.4%17.9%17.0%5.0%12.8%
Interest Income1.33M912K12.78M8.01M6.4M
Interest Expense56.97M54.26M85.08M83.54M100.22M
Other Income / Expenses(68.63M)(53.81M)(72.3M)(75.54M)(231.25M)
Income Before Tax559.47M445.92M434.01M75.48M24.55M
Pre-Tax Margin19.9%16.0%14.6%2.5%1.2%
Income Tax Expense74.35M83M76.44M5.32M(33.98M)
Net Income485.37M363.14M356.33M69.68M(905.64M)
Net Margin17.3%13.0%12.0%2.3%-45.4%
EPS (Basic)10.387.747.581.49(20.30)
EPS (Diluted)10.237.687.531.48(20.25)
Weighted Avg Shares46.77M46.9M46.98M46.84M44.62M
Weighted Avg Shares (Diluted)47.43M47.31M47.3M47.09M44.72M

Teleflex Incorporated

NYSE:TFX

Intrinsic Alpha fair value

Locked

Current Price

$165.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.